WhatsApp
backNews Article

Bharat Parenterals Limited Clarifies No Undisclosed Events Causing Recent Stock Price Changes

Company confirms full compliance with SEBI regulations and attributes stock price movement to market factors

Bharat Parenterals Limited has responded to BSE's query regarding significant stock price movement, confirming no undisclosed material events or impending announcements. The company states that recent price changes are market driven and reaffirms compliance with SEBI listing regulations.

19 hours ago|BPLPHARMA+0.00%
Bharat Parenterals Limited541096General / Other

Bharat Parenterals Limited

General / Other

Bharat Parenterals Limited officially replied to a BSE inquiry about significant stock price movements, stating no undisclosed information or material events influenced the changes and affirming regulatory compliance.

The company stated that it is unaware of any undisclosed information or impending announcements that could affect its stock price or trading volume.

Bharat Parenterals confirmed full adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including prompt disclosure of all material information to stock exchanges.

The company attributes recent securities price movements solely to market forces, with no underlying corporate developments driving the change.

Bharat Parenterals reiterated its ongoing commitment to high standards of corporate governance, transparency, and timely disclosure as required by law.

Highlights

  • Bharat Parenterals responded to a BSE query dated November 19, 2026, about stock price movement.
  • The company confirmed no undisclosed material events or impending announcements exist.
  • Recent stock price changes are deemed market driven by the company.
  • Full compliance with SEBI Listing Regulations has been maintained.
  • The reply was signed by Sharmin Soni, Company Secretary and Compliance Officer.

Key Data Snapshot

Date of response letterNovember 20, 2026
Scrip code541096
Reference letter from BSEL/SURV/ONL/PV/SJ/2026-2027/4465 dated November 19, 2026
Company secretarySharmin Soni
Membership numberACS-75694

What happened

  • Bharat Parenterals Limited provided an official response to the BSE regarding unusual price movements in its securities.
  • The company declared no undisclosed events or information impacted its share price.
  • It attributed price movements to general market conditions without any material corporate developments.

Regulatory and governance context

  • The company confirmed compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • All material information has been promptly disclosed to stock exchanges as required by law.
  • The communication reaffirmed Bharat Parenterals' commitment to sustained transparency and governance standards.

More News on General / Other

View all

Latest corporate announcements and market updates in General / Other.

View all news
Bharat Parenterals Limited Clarifies No Undisclosed Events…